GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rhoen Klinikum AG (XTER:RHK) » Definitions » ROE %

Rhoen Klinikum AG (XTER:RHK) ROE % : 5.00% (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Rhoen Klinikum AG ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Rhoen Klinikum AG's annualized net income for the quarter that ended in Dec. 2023 was €62 Mil. Rhoen Klinikum AG's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was €1,245 Mil. Therefore, Rhoen Klinikum AG's annualized ROE % for the quarter that ended in Dec. 2023 was 5.00%.

The historical rank and industry rank for Rhoen Klinikum AG's ROE % or its related term are showing as below:

XTER:RHK' s ROE % Range Over the Past 10 Years
Min: 0.12   Med: 3.49   Max: 85.31
Current: 3.14

During the past 13 years, Rhoen Klinikum AG's highest ROE % was 85.31%. The lowest was 0.12%. And the median was 3.49%.

XTER:RHK's ROE % is ranked worse than
54.92% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs XTER:RHK: 3.14

Rhoen Klinikum AG ROE % Historical Data

The historical data trend for Rhoen Klinikum AG's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhoen Klinikum AG ROE % Chart

Rhoen Klinikum AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.77 0.12 2.39 2.08 3.13

Rhoen Klinikum AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 2.04 1.87 3.63 5.00

Competitive Comparison of Rhoen Klinikum AG's ROE %

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's ROE % distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's ROE % falls into.



Rhoen Klinikum AG ROE % Calculation

Rhoen Klinikum AG's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=38.712/( (1223.802+1252.04)/ 2 )
=38.712/1237.921
=3.13 %

Rhoen Klinikum AG's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=62.204/( (1237.058+1252.04)/ 2 )
=62.204/1244.549
=5.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Rhoen Klinikum AG  (XTER:RHK) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=62.204/1244.549
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(62.204 / 1500.096)*(1500.096 / 1764.409)*(1764.409 / 1244.549)
=Net Margin %*Asset Turnover*Equity Multiplier
=4.15 %*0.8502*1.4177
=ROA %*Equity Multiplier
=3.53 %*1.4177
=5.00 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=62.204/1244.549
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (62.204 / 79.48) * (79.48 / 56.852) * (56.852 / 1500.096) * (1500.096 / 1764.409) * (1764.409 / 1244.549)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.7826 * 1.398 * 3.79 % * 0.8502 * 1.4177
=5.00 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Rhoen Klinikum AG ROE % Related Terms

Thank you for viewing the detailed overview of Rhoen Klinikum AG's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhoen Klinikum AG (XTER:RHK) Business Description

Traded in Other Exchanges
Address
Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.

Rhoen Klinikum AG (XTER:RHK) Headlines

No Headlines